Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Trading Up 38.5 %

Shares of NYSE:AMPE opened at $0.00 on Monday. The firm has a market cap of $4,086.00, a PE ratio of 0.00 and a beta of 3.66. The company has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.05. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.91.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.